Cigna Corporation (CI)
Last Price$311.50.9%
Market Cap$87.2B
CI Rating
CI Quality rating performance
CI Intrinsic Value
Key Highlights:
As of Mar 03, 2025 CI Relative Value is $318.1, which is undervalued by 2.1%, compared to current share price of $311.5.
As of Mar 03, 2025 CI DCF Value is $1,556.8, which is undervalued by 399.8%, compared to current share price of $311.5.
CI Share Price History
1W 3.5%
1M 6.5%
6M (14.1%)
YTD 2.1%
1Y (6.0%)
3Y 37.8%
5Y 76.3%
10Y 175.9%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
CI Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$87.2B
$110.9B
$245.3B
$8,957.0M
Shares Outstanding
280M
Employees
N/A
Growth (CAGR)
9.8%
(4.5%)
(1.98%)
24.7%
62.23%
Profitability
48.9%
2.6%
4.2%
3.7%
246.6%
Intrinsic Value
$942.9 (202.7% undervalued)
$1,567.7
$318.1
$437.8
$727.4
78.7%
Return on Capital
Financial Health
$8,215.0M
$23.8B
2.7x
4.5x
77.5%
Dividends
N/A
1.8%
17.5%
Dec 04, 2024
Earnings
Apr 30, 2025
BEAT by 6.6%
BEAT by 3.7%
(4.2%)
10 Beat & null Miss
CI Stock Financials
CI Income Statement Metrics
Annual
Quarterly
LTM
CI Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$11.8B +36.5% YoY
Capital Expenditure (CAPEX)
($1,573.0M) +21.5% YoY
Free Cash Flow (FCF)
$10.2B +39.1% YoY
CI Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$195.2B 8.4% YoY
Pre-tax income
$5,513.0M (34.3%) YoY
2.8% margin
CI Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$152.8B
Current assets ($37.4B, 24.5% of total)
$8,747.0M (5.7%)
$23.7B (15.5%)
Other current assets
$4,925.0M (3.2%)
Non-current assets ($115.4B, 75.5% of total)
$18.0B (11.8%)
$4,065.0M (2.7%)
$30.9B (20.2%)
Other non-current assets
$62.5B (40.9%)
Financial position
$22.1B
Cash & Short-term
Investments
Total Debt
CI Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
CI Earnings Surprises
Crunching data... Almost there!
CI Dividends
CI Dividend Yield
Crunching data... Almost there!
CI Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with CI
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
FAQ
What is Cigna Corporation (CI) stock rating?
As of today, Cigna Corporation has a stock rating of 6 (out of 10), which is considered Good.
is Cigna Corporation (CI) a good stock to buy?
As of today, Cigna Corporation has a Good stock rating, which is 202.7% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.